Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Paul A. Friedman currently holds 187,164 shares of Cerulean Pharma Inc. (CERU), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul A. Friedman has been a net seller of CERU stock. They have purchased $1.4M and sold $311.5M worth of shares.
Paul A. Friedman's most recent insider trade was on Jan 9, 2026, when they sold 280 shares at $0.00 per share.
Paul A. Friedman serves as Executive at Cerulean Pharma Inc. (CERU). They have executed 249 insider transactions totaling $312.9M over their tenure at the company.
Paul A. Friedman holds the position of Executive at Cerulean Pharma Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Paul A. Friedman has shown a selling trading pattern, with $1.4M in total purchases and $311.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Paul A. Friedman was on Aug 13, 2025, when they sold $10.8M worth of MDGL shares. This transaction involved 28,976 shares at $372.39 per share.
Paul A. Friedman currently owns 187,164 shares of Cerulean Pharma Inc. (CERU), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Paul A. Friedman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Paul A. Friedman has 249 Form 4 filings on record as an insider at Cerulean Pharma Inc..
Set alerts for Paul A. Friedman and 40,000+ other insiders.